Literature DB >> 12230126

Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats.

Jale Balkan1, Oznur Kanbağli, Gülçin Aykaç-Toker, Müjdat Uysal.   

Abstract

In this study, we evaluated whether taurine treatment has a protective effect on the prooxidant-antioxidant state following chronic ethanol treatment in rats. Rats were given water containing 20% ethanol (v/v) as drinking water for 3 months. Chronic ethanol treatment in drinking water resulted in increased oxidative stress in the liver of rats. Taurine treatment was performed by adding 1% taurine (w/v) to the drinking water plus injection (400 mg/kg body weight) intraperitoneally 3 times/week for 28 d after ethanol cessation in chronically ethanol-treatad rats. This treatment starting after ethanol cessation caused a significant decreases in serum transaminase activities and hepatic total lipid, triglyceride, malondialdehyde, and diene conjugate levels and significant increases in hepatic glutathione, vitamin E, and vitamin C levels, but did not alter the activities of superoxide dismutase, glutathione peroxidase, and glutathione transferase in the liver as compared with chronically ethanol-treated rats. Accordingly, we propose that taurine has a restorative effect on ethanol-induced hepatic damage by decreasing oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230126     DOI: 10.1248/bpb.25.1231

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  12 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  Peroxynitrite induced decrease in Na+, K+-ATPase activity is restored by taurine.

Authors:  Necla Kocak-Toker; Murat Giris; Feti Tülübas; Müjdat Uysal; Gülcin Aykac-Toker
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

3.  Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumption.

Authors:  Calivarathan Latchoumycandane; Laura E Nagy; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2015-05-21       Impact factor: 7.376

4.  Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation.

Authors:  Calivarathan Latchoumycandane; Laura E Nagy; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2014-01-08       Impact factor: 7.376

5.  Effect of taurine on endotoxin-induced alterations in plasma asymmetric dimethylarginine, L-arginine and nitric oxide in guinea pigs.

Authors:  Barbaros Balabanli; Hüsamettin Erdamar; Nurten Türközkan; Halil Yaman; Yasemin Kurt
Journal:  J Thromb Thrombolysis       Date:  2007-02-20       Impact factor: 5.221

6.  The restorative effect of taurine on experimental nonalcoholic steatohepatitis.

Authors:  Si-Wen Chen; Yue-Xiang Chen; Jian Shi; Yong Lin; Wei-Fen Xie
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.487

7.  Protective action of taurine, given as a pretreatment or as a posttreatment, against endotoxin-induced acute lung inflammation in hamsters.

Authors:  Tapan M Bhavsar; Sanket N Patel; Cesar A Lau-Cam
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

8.  Neuroprotective Mechanisms of Taurine against Ischemic Stroke.

Authors:  Janet Menzie; Howard Prentice; Jang-Yen Wu
Journal:  Brain Sci       Date:  2013-06-03

9.  The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease

Authors:  İlknur Bingül; A. Fatih Aydın; Canan Küçükgergin; Işın Doğan-Ekici; Semra Doğru-Abbasoğlu; Müjdat Uysal
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

10.  Metabonomics-based study of clinical urine samples in suboptimal health with different syndromes.

Authors:  Hai-Zhen Cui; Li-Min Wang; Xin Zhao; Yue-Yun Liu; Shao-Xian Wang; Xiao-Hong Li; You-Ming Jiang; Jia-Xu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.